[1]
“Glutamate Receptor Modulation as a Therapeutic Strategy in Neurodegenerative Diseases: Mechanisms, Pharmacological Targets, and Future Perspectives”, Int J Res Pharm Hos & Clin. Pharm, vol. 7, no. 4, Mar. 2026, Accessed: Apr. 03, 2026. [Online]. Available: https://www.rubatosis.org/journals/index.php/ijrhcp/article/view/253